This is corroborated by a study that included tumors from 91 patients, which demonstrated that TP53 mutations were only present in MCPyV-DNA-negative tumors, highlighting another distinct feature between the two MCC subtypes [64]. This evidence concerns the gene TP53 and Merkel cell skin cancer.